Cooray Neuroconsulting AB

Active
559454-0709Limited company (AB)Registered 2023STOCKHOLM

Key figures

1 121 000 kr+4,3%
Revenue 2025
+4,3%
Average annual growth 2024–2025
0500 k1 m1,5 m20242025

Key figures

2025

Summary: Cooray Neuroconsulting AB

What kind of company is it?

Cooray Neuroconsulting AB (org. no. 559454-0709) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Stockholm. Industry according to Statistics Sweden: specialist medical practice activities, at hospitals (SNI 86221).

How is the company doing financially?

Net sales in financial year 2025 were 1 121 000 kr, up 4,3 % on the previous year (1 075 000 kr). Net profit for 2025 was 625 584 kr (55,8 % of net sales). At the end of financial year 2025, total assets were 1 339 331 kr and equity 975 379 kr (equity ratio 72,8 %). The annual report for 2025 proposes a dividend of 322 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 322 000 kr.

History
2025322 000 kr
2024400 000 kr
Summary of annual reports2024–2025
20242025
Sales revenue1 075 0001 121 000
Profit for the reporting year724 795625 584
Retained earnings of previous periods——
Total assets1 043 6131 339 331
Total liabilities293 818363 952
Total equity749 795975 379
Employees——
Proposed dividend400 000322 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.